Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Strunk

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Vaccines|July 16, 2020
Impact of Helminth Infections during Pregnancy on Vaccine Immunogenicity in Gabonese InfantsJudith Flügge, Ayôla Akim Adegnika, Yabo Josiane Honkpehedji, et al.
Communications Biology|May 19, 2026
The MYB-related transcription factor MYPOP acts as a selective regulator of cancer cell growthJohannes Strunk, Alena Hüppner, Mahwish Sial, et al.
Lancet (London, England)|February 16, 2024
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trialJuergen Rech, Koray Tascilar, Melanie Hagen, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Vaccines|July 16, 2020
Impact of Helminth Infections during Pregnancy on Vaccine Immunogenicity in Gabonese InfantsJudith Flügge, Ayôla Akim Adegnika, Yabo Josiane Honkpehedji, et al.
Communications Biology|May 19, 2026
The MYB-related transcription factor MYPOP acts as a selective regulator of cancer cell growthJohannes Strunk, Alena Hüppner, Mahwish Sial, et al.
Lancet (London, England)|February 16, 2024
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trialJuergen Rech, Koray Tascilar, Melanie Hagen, et al.
Pageof 4